Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Dev Comp Immunol. 2011 Apr 19;35(8):850–856. doi: 10.1016/j.dci.2011.03.018

Fig. 5.

Fig. 5

LPS-enhanced clearance of phagocytized bacteria appears dependent on TirA. The clearance of Syto9-fluorescently labeled S. aureus 45 min following phagocytosis in AX2, TirA-deficient and Nramp-deficient cells treated with or without 1 μg/mL ultra-pure LPS or Lipid A was measured as in Fig 2. Shown are means and SEM from at least three independent experiments. * refers to a statistically-significant difference (p<0.05, t-test) between LPS or Lipid A-treated and untreated cells.